Jun 01,2017

Flatiron Health Announces Strategic Collaboration with the National Cancer Institute to Explore Use of Real-World Evidence in Clinical Trial Design

Flatiron Health today announced a collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to explore how real-world evidence derived from de-identified patient data captured at the point of care can be used for clinical trial design and prospective research studies.

COLLABORATION PARTNERSHIP

#r&d

#rwe

View Analyst & Ambassador Comments
Go to original news
Nov 01,2016

Flatiron Health Achieves HITRUST CSF Certification

Flatiron Health, a healthcare technology company providing software and data analytics services to cancer researchers and care providers, today announced that three of its systems – OncoAnalytics, OncoEMR and Outcomes Database – have earned Certified status for information security by the Health Information Trust (HITRUST) Alliance.

PRODUCT

#rwe

View Analyst & Ambassador Comments
Go to original news
Jul 01,2016

Tennessee Oncology and Flatiron Health Partner to Advance the Development of Value-Based Care Products and Services

Tennessee Oncology and Flatiron Health today announced a collaboration that will focus on the development of value-based care solutions for cancer care providers to leverage in today’s rapidly evolving reimbursement landscape. In addition, Tennessee Oncology, one of the largest private, community-based practices in the nation, will utilize Flatiron Health’s OncoEMR®, OncoAnalytics® and new value-based care solution to help ensure successful participation in the Centers for Medicare and Medicaid Services Oncology Care Model (OCM) program.

COLLABORATION PARTNERSHIP

#institution

#rwe

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jun 01,2016

Flatiron Health Unveils the Next Version of its Oncology Software Suite: OncoCloud

Flatiron Health, the leader in cloud-based oncology software and analytics, today unveiled OncoCloudTM – the next version of its cloud-based software suite that includes OncoEMR®, OncoAnalytics® and OncoBilling®. In addition to key updates to its core products, the company added a new solution to enable its clients to participate in value-based care initiatives like the Oncology Care Model (OCM). Together, the suite is the industry’s most comprehensive cloud-based software offering for community oncology practices.

PRODUCT

#ai/software

#rwe

View Analyst & Ambassador Comments
Go to original news
May 01,2016

The Center for Cancer and Blood Disorders Selects Flatiron Health OncoEMR to Support Its Transition to Value-Based Care

Flatiron Health announced today that The Center for Cancer and Blood Disorders, a comprehensive community oncology practice with nine locations in the Fort Worth, Texas region, selected OncoEMR® as their medical oncology electronic health record solution to support long-term value-based care initiatives and meet the practice’s evolving technology needs.

PRODUCT

#connected device

#rwe

View Analyst & Ambassador Comments
Go to original news
May 01,2016

Flatiron Health and the FDA Embark on Cancer Research Collaboration

Flatiron Health and the U.S. Food and Drug Administration (FDA) have signed a research collaboration agreement to determine how real-world evidence derived from de-identified, HIPAA-compliant patient data captured outside of clinical trials can provide new insights into the safety and effectiveness of emerging anti-cancer therapies such as immunotherapeutic agents.

COLLABORATION PARTNERSHIP

#r&d

#rwe

View Analyst & Ambassador Comments
Go to original news
Apr 01,2016

Flatiron Health Announces Strategic Relationships with Celgene and Amgen to Further Advance Personalized Medicine for Cancer Patients and Accelerate Clinical Research

Flatiron Health today announced an expansion of its relationships with Celgene Corporation and Amgen Inc. Through individual agreements, Celgene and Amgen will collaborate with Flatiron Health with the goals of accelerating clinical research, advancing personalized medicine and enhancing treatment options for cancer patients. In addition, Celgene Switzerland LLC and Amgen Ventures have invested in Flatiron Health’s recently announced fundraising round.

COLLABORATION PARTNERSHIP

#r&d

#rwe

#rwd

View Analyst & Ambassador Comments
Go to original news
Nov 01,2015

Flatiron Health Unveils New Features and Enhancements to the OncoCloud Software Platform

Flatiron Health today announced new features and enhancements to its OncoCloud software platform. Currently, the platform is used by over 2,000 clinicians to support the treatment of nearly one million active cancer patients, and helps community oncology practices and cancer centers enhance patient care, optimize workflow and thrive in today’s healthcare environment.

PRODUCT

#platform

#rwe

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 08,2014

Flatiron Health and Vector Oncology to Offer Patient-Reported Outcomes at the Point of Care

Flatiron Health and Vector Oncology today announced a partnership that enables oncology providers to easily gather and view patient-reported symptoms at the point of care by using Vector Oncology’s Patient Care Monitor™ integrated with OncoEMR®. OncoEMR is a cloud-based electronic medical record (EMR) designed to address key concerns within an oncology clinic: treatment, disease and business management. In addition, Flatiron Health and Vector Oncology will collaborate on various studies involving health outcomes and economic endpoints in support of clinical research efforts and real-world evidence generation

COLLABORATION PARTNERSHIP

#connected device

#ai/software

#rwe

View Analyst & Ambassador Comments
Go to original news
Subscribe to RWE